US equities |
MU $931.24 ▲+1.87% NVDA $217.23 ▼-1.84% SNDK $1,394.83 ▼-0.61% AMD $562.23 ▼-1.50% SPCX $148.62 ▼-2.33% INTC $95.37 ▼-2.80% AAPL $342.00 ▼-0.28% MSFT $539.44 ▲+1.08%
FinancialContent

Nemaura Medical Inc. - Common Stock (NQ:NMRD)

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nemaura Medical Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues
Via Investor Brand Network
Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Producing What Was Thought to Be Implausible
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions Worldwide
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
Via Investor Brand Network
Topics Artificial Intelligence
Nemaura (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing, Distribution Scale-Up
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring’s Exponential Growth Rate
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’
Via Investor Brand Network
Topics Artificial Intelligence
Nemaura Medical (NASDAQ: NMRD) Appoints Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Appoints Technical Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Marks History-Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
Nemaura Medical (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution
Via Investor Brand Network
< Previous 1 2 3 4 5 Next >